These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2112960

  • 1. Paradoxical growth-hormone responses to thyrotropin-releasing hormone in panic disorder.
    Tancer ME, Stein MB, Uhde TW.
    Biol Psychiatry; 1990 Jun 01; 27(11):1227-30. PubMed ID: 2112960
    [Abstract] [Full Text] [Related]

  • 2. Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder.
    Rapaport MH, Risch SC, Gillin JC, Golshan S, Janowsky DS.
    Am J Psychiatry; 1989 Jan 01; 146(1):92-5. PubMed ID: 2492166
    [Abstract] [Full Text] [Related]

  • 3. Is there paradoxical growth hormone response to thyrotropin-releasing hormone in depression?
    Hsiao JK, Garbutt JC, Loosen PT, Mason GA, Prange AJ.
    Biol Psychiatry; 1986 Jun 01; 21(7):595-600. PubMed ID: 3085739
    [Abstract] [Full Text] [Related]

  • 4. Influence of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in uremic patients.
    Díez JJ, Iglesias PL, Sastre J, Gómez-Pan A, Selgas R, Martínez-Ara J, Miguel JL, Méndez J.
    Kidney Int; 1994 Nov 01; 46(5):1387-91. PubMed ID: 7853798
    [Abstract] [Full Text] [Related]

  • 5. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
    Uhde TW, Tancer ME, Rubinow DR, Roscow DB, Boulenger JP, Vittone B, Gurguis G, Geraci M, Black B, Post RM.
    Neuropsychopharmacology; 1992 Feb 01; 6(2):101-18. PubMed ID: 1610485
    [Abstract] [Full Text] [Related]

  • 6. Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics.
    Barbarino A, Corsello SM, Tofani A, Sciuto R, Della Casa S, Rota CA, Colasanti S, Barini A.
    Metabolism; 1992 Sep 01; 41(9):949-53. PubMed ID: 1355581
    [Abstract] [Full Text] [Related]

  • 7. TSH response to TRH in depression with and without panic attacks.
    Gillette GM, Garbutt JC, Quade DE.
    Am J Psychiatry; 1989 Jun 01; 146(6):743-8. PubMed ID: 2499197
    [Abstract] [Full Text] [Related]

  • 8. Endocrine responses to growth hormone-releasing hormone, thyrotropin-releasing hormone and corticotropin-releasing hormone in depression.
    Lesch KP, Müller U, Rupprecht R, Kruse K, Schulte HM.
    Acta Psychiatr Scand; 1989 Jun 01; 79(6):597-602. PubMed ID: 2548370
    [Abstract] [Full Text] [Related]

  • 9. TSH and catecholamine response to TRH in panic disorder.
    Castellani S, Quillen MA, Vaughan DA, Hund MA, Ho L, Ziegler MG, Le Vine WR.
    Biol Psychiatry; 1988 May 01; 24(1):87-90. PubMed ID: 3130900
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and biological correlates of panic states.
    Lapierre YD.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 May 01; 11(2-3):91-6. PubMed ID: 3114829
    [Abstract] [Full Text] [Related]

  • 11. Pituitary adrenocortical unresponsiveness in lactate-induced panic.
    Levin AP, Doran AR, Liebowitz MR, Fyer AJ, Gorman JM, Klein DF, Paul SM.
    Psychiatry Res; 1987 May 01; 21(1):23-32. PubMed ID: 3037579
    [Abstract] [Full Text] [Related]

  • 12. Abnormal growth hormone responses to CB-154 and thyrotropin-releasing hormone (TRH) in patients with acromegaly.
    Hanew K, Aida M, Sasaki A, Mouri T, Yoshinaga K.
    Tohoku J Exp Med; 1979 Jan 01; 127(1):53-62. PubMed ID: 104407
    [Abstract] [Full Text] [Related]

  • 13. Involvement of a dopaminergic mechanism in the response of growth hormone to thyrotropin releasing hormone in patients with major depression.
    Marchesi C, Gnudi A, Chiodera P, De Risio C, Fava A, Dasso L, De Ferri A, Guerra M, Coiro V.
    Pharmacopsychiatry; 1987 Mar 01; 20(2):64-6. PubMed ID: 3108910
    [Abstract] [Full Text] [Related]

  • 14. Panic disorder, vertigo, and the protirelin (TRH) test.
    Hamlin CL.
    Psychiatry Res; 1988 Mar 01; 23(3):349-50. PubMed ID: 3133685
    [No Abstract] [Full Text] [Related]

  • 15. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
    De Marinis L, Mancini A, Zuppi P, Fiumara C, Conte G, Sammartano L, Fabrizi ML, Valle D.
    Exp Clin Endocrinol Diabetes; 1996 Mar 01; 104(1):67-71. PubMed ID: 8750573
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone response to clonidine in panic disorder patients.
    Schittecatte M, Charles G, Depauw Y, Mesters P, Wilmotte J.
    Psychiatry Res; 1988 Feb 01; 23(2):147-51. PubMed ID: 3363023
    [Abstract] [Full Text] [Related]

  • 17. Blunted growth hormone response to clonidine in panic disorder patients.
    Uhde TW, Vittone BJ, Siever LJ, Kaye WH, Post RM.
    Biol Psychiatry; 1986 Sep 01; 21(11):1081-5. PubMed ID: 3741921
    [No Abstract] [Full Text] [Related]

  • 18. The hypothalamic-pituitary-thyroid axis in agoraphobia, panic disorder, major depression and normal controls.
    Hofmann PJ, Nutzinger DO, Kotter MR, Herzog G.
    J Affect Disord; 2001 Sep 01; 66(1):75-7. PubMed ID: 11532535
    [Abstract] [Full Text] [Related]

  • 19. Reduced TSH and prolactin responses to TRH in patients with panic disorder.
    Roy-Byrne PP, Uhde TW, Rubinow DR, Post RM.
    Am J Psychiatry; 1986 Apr 01; 143(4):503-7. PubMed ID: 3082224
    [Abstract] [Full Text] [Related]

  • 20. Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder.
    Brambilla F, Perna G, Garberi A, Nobile P, Bellodi L.
    Psychoneuroendocrinology; 1995 Apr 01; 20(1):1-9. PubMed ID: 7838898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.